SPRINGWORKS THERAPEUTICS INC's ticker is SWTX and the CUSIP is 85205L107. A total of 125 filers reported holding SPRINGWORKS THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $7,396,342 | -9.8% | 319,911 | +2.3% | 1.35% | +5.2% |
Q2 2023 | $8,197,028 | +0.3% | 312,625 | -1.6% | 1.28% | -6.3% |
Q1 2023 | $8,175,668 | -0.7% | 317,625 | +0.3% | 1.37% | -22.7% |
Q4 2022 | $8,235,416 | -4.3% | 316,625 | +5.0% | 1.77% | +48.1% |
Q3 2022 | $8,605,000 | -34.9% | 301,625 | -43.8% | 1.19% | -15.5% |
Q2 2022 | $13,213,000 | -60.0% | 536,664 | -8.3% | 1.41% | -69.7% |
Q1 2022 | $33,019,000 | +55.5% | 585,025 | +70.8% | 4.67% | +99.9% |
Q4 2021 | $21,232,000 | +35.0% | 342,566 | +38.2% | 2.33% | +76.7% |
Q3 2021 | $15,728,000 | -2.2% | 247,917 | +27.1% | 1.32% | +21.4% |
Q2 2021 | $16,080,000 | +58.8% | 195,117 | +41.7% | 1.09% | +40.0% |
Q1 2021 | $10,129,000 | +346.2% | 137,672 | +339.8% | 0.78% | +286.6% |
Q4 2020 | $2,270,000 | -70.5% | 31,300 | -84.4% | 0.20% | -68.3% |
Q4 2019 | $7,698,000 | +14.5% | 200,000 | -35.5% | 0.63% | -38.9% |
Q3 2019 | $6,721,000 | – | 310,000 | – | 1.04% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Bain Capital Life Sciences Investors, LLC | 7,281,307 | $347,100,000 | 32.35% |
BVF INC/IL | 2,053,991 | $97,914,000 | 5.33% |
Samsara BioCapital, LLC | 398,017 | $18,973,000 | 5.29% |
Orbimed Advisors | 7,406,307 | $353,059,000 | 4.44% |
Consonance Capital Management LP | 602,732 | $28,732,000 | 3.50% |
Boxer Capital, LLC | 2,075,905 | $98,958,000 | 3.42% |
Perceptive Advisors | 3,481,148 | $165,946,000 | 2.42% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,234,262 | $58,837,000 | 1.43% |
DRIEHAUS CAPITAL MANAGEMENT LLC | 974,915 | $46,474,000 | 0.95% |
HighVista Strategies LLC | 11,477 | $547,000 | 0.40% |